De Lisle Partners’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,000
| Closed | -$504K | – | 183 |
|
|
2025
Q1 | $504K | Hold |
50,000
| – | – | 0.08% | 167 |
|
|
2024
Q4 | $592K | Sell |
50,000
-40,000
| -44% | -$473K | 0.09% | 169 |
|
|
2024
Q3 | $1.04M | Hold |
90,000
| – | – | 0.17% | 138 |
|
|
2024
Q2 | $951K | Hold |
90,000
| – | – | 0.21% | 119 |
|
|
2024
Q1 | $950K | Buy |
+90,000
| New | +$950K | 0.22% | 115 |
|